These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 36837507)

  • 1. Morphopathogenesis of Adult Acquired Cholesteatoma.
    Dambergs K; Sumeraga G; Pilmane M
    Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837507
    [No Abstract]   [Full Text] [Related]  

  • 2. Complex Evaluation of Tissue Factors in Pediatric Cholesteatoma.
    Dambergs K; Sumeraga G; Pilmane M
    Children (Basel); 2021 Oct; 8(10):. PubMed ID: 34682191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Tissue Factors in the Ontogenetic Aspects of Human Cholesteatoma.
    Dambergs K; Sumeraga G; Pilmane M
    Diagnostics (Basel); 2024 Mar; 14(6):. PubMed ID: 38535082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remodeling Factors, Transcription Factors and Angiogenetic Factors in Cholesteatoma in Ontogenetic Aspect.
    Dambergs K; Sumeraga G; Pilmane M
    Iran J Otorhinolaryngol; 2022 Mar; 34(121):71-81. PubMed ID: 35655767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic value of matrix metalloproteinase 9 and tissue inhibitor of matrix metalloproteinases 1 in cholesteatoma.
    Olszewska E; Matulka M; Mroczko B; Pryczynicz A; Kemona A; Szmitkowski M; Mierzwinski J; Pietrewicz T
    Histol Histopathol; 2016 Mar; 31(3):307-15. PubMed ID: 26490574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The significance of keratinocyte in hyperproliferation of middle ear cholesteatoma].
    Zhu Z; Hong Y; Wang Y; He G; Ye S
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Jan; 30(2):139-43. PubMed ID: 27192911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of the angiogenesis of acquired middle ear cholesteatomas by inhibitor of DNA binding transcription factor.
    Fukudome S; Wang C; Hamajima Y; Ye S; Zheng Y; Narita N; Sunaga H; Fujieda S; Hu X; Feng L; Lin J
    JAMA Otolaryngol Head Neck Surg; 2013 Mar; 139(3):273-8. PubMed ID: 23657791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunomorphological evaluation of cholesteatoma].
    Kuczkowski J; Bakowska A; Mikaszewski B
    Otolaryngol Pol; 2004; 58(2):289-95. PubMed ID: 15307474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Basic fibroblast growth factor (b-FGF) in the perimatrix of cholesteatoma].
    Milewski C; Fedorowski A; Stan AC; Walter GF
    HNO; 1998 Sep; 46(9):804-8. PubMed ID: 9816534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiogenesis and angiogenic growth factors in middle ear cholesteatoma.
    Sudhoff H; Dazert S; Gonzales AM; Borkowski G; Park SY; Baird A; Hildmann H; Ryan AF
    Am J Otol; 2000 Nov; 21(6):793-8. PubMed ID: 11078065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of transforming growth factor-beta 1 matrix metalloproteinase-1 and its inhibitor in human middle ear cholesteatoma].
    Yang X; Li X; Ma M; Zhang L; Zhang Q; Wang J; Wang B
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2002 Apr; 37(2):121-3. PubMed ID: 12768723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of significant gene expression changes in congenital and acquired cholesteatoma.
    Kaya İ; Avcı ÇB; Şahin FF; Özateş NP; Sezgin B; Kurt CÇ; Bilgen C; Kirazlı T
    Mol Biol Rep; 2020 Aug; 47(8):6127-6133. PubMed ID: 32740796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Detection and correlation of lipopolysaccharide, vitamin D receptor and matrix metalloproteinase-9 in the middle ear cholesteatoma].
    Li Y; Xu Z; Zhang L; Quan C; Lin X
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Aug; 26(16):739-41, 746. PubMed ID: 23213753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Current concepts of the pathogenesis of acquired middle ear cholesteatoma].
    Welkoborsky HJ
    Laryngorhinootologie; 2011 Jan; 90(1):38-48; quiz 49-50. PubMed ID: 21225533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perimatrix of middle ear cholesteatoma: A granulation tissue with a specific transcriptomic signature.
    Jovanovic I; Zivkovic M; Djuric T; Stojkovic L; Jesic S; Stankovic A
    Laryngoscope; 2020 Apr; 130(4):E220-E227. PubMed ID: 31132150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholesteatoma epithelium is characterized by increased expression of Ki-67, p53 and p21, with minimal apoptosis.
    Huisman MA; De Heer E; Grote JJ
    Acta Otolaryngol; 2003 Apr; 123(3):377-82. PubMed ID: 12737294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression patterns of p27Kip1 and Ki-67 in cholesteatoma epithelium.
    Chae SW; Song JJ; Suh HK; Jung HH; Lim HH; Hwang SJ
    Laryngoscope; 2000 Nov; 110(11):1898-901. PubMed ID: 11081606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The expression of matrix metalloproteinase-1 and interleukin-1-alpha messenger ribonucleic acid in human middle ear cholesteatoma].
    Liu J; Lin G; Huang J; Jiang Z
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2002 Feb; 37(1):30-3. PubMed ID: 12768791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunohistochemical studies with middle ear mucosal remnants in cholesteatoma].
    Sudhoff H; Borkowski G; Bujia J; Hildmann H; Fisseler-Eckhoff A
    HNO; 1997 Aug; 45(8):630-5. PubMed ID: 9378670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of cytokines and cell cycle regulating substances in proliferation of cholesteatoma epithelium.
    Tanaka Y; Kojima H; Miyazaki H; Koga T; Moriyama H
    Laryngoscope; 1999 Jul; 109(7 Pt 1):1102-7. PubMed ID: 10401849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.